The glucocorticoid receptor (GR) is a DNA-binding protein that can regulate the transcription of a large number of genes in a ligand-dependent fashion. Although much progress has been made on the mechanism of transcriptional regulation by GR, a potential allosteric effect of GR-binding ligands on specific GR-DNA interactions is controversial. In this study, gel-shift methods are used to measure the effects of a classical agonist dexamethasone and a prototypical antagonist RU486 on the in vitro interactions of GR with DNA substrates, which contain glucocorticoid response elements (GREs) from promoters of GR-regulated genes. These studies show that cell extracts containing human GR bind specifically and with high affinity to GREs in the absence of ligand. An agonist dexamethasone and antagonist RU486 do not affect the affinity of GR for DNA but subtly alter the electrophoretic mobility of the GR-DNA complex. Importantly, the dissociation rate of GR from DNA increases as a function of the concentration of GRE-containing DNA. At a fixed DNA concentration, dexamethasone-bound GR dissociates from DNA significantly faster than does ligand-free GR or RU486-bound GR. These results are consistent with a model for transcriptional activation in which a dynamic complex is formed between agonist-bound GR and DNA.
The glucocorticoid receptor (GR)1 is a member of the steroid hormone receptor family of transcription factors that regulates a large number of genes in a hormone-or ligand-dependent manner. GR is predominantly cytosolic and requires association with heat shock proteins for ligand binding, a feature that has complicated in vitro structural studies of GR (1-6). The molecular mechanism by which hormones and small molecule ligands regulate GR-mediated gene expression is not clearly understood. A favored model is that hormone binding induces dissociation of heat shock proteins from the ligand-bound GR complex, which then translocates to the nucleus for sequencespecific DNA binding to GREs (7-10). However, the underlying mechanism for the expression of agonist versus antagonist activity for the steroid-bound GR-DNA complex is not clear.Attempts to study the allosteric effects of hormones on GR-DNA interactions in vitro have led to contradictory observations. In general, studies indicate that hormones are not required for stable GR binding to DNA in vitro (11-16). Specifically, complexes of agonist triamcinolone acetonide and antagonist RU486 bound to GR have a comparable affinity for glucocorticoid response elements from different promoters (14 -16). In contrast to these studies done on asymmetric GR binding sites, gel-shift experiments reported with GR and an artificial palindromic GRE suggest that ligands directly affect GR-DNA binding (17). The agonist dexamethasone enhances GR-DNA binding severalfold, whereas antagonists including RU486 have no effect on GR-DNA binding. However, this observation is contested by a report that also implements gelshift methods with a palindromic GRE substrate but uses in vitro transcribed...